PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF OXPRENOLOL IN MAN USING CONTINUOUS NON-INVASIVE BLOOD-PRESSURE MONITORING

被引:8
作者
KOOPMANS, R
OOSTERHUIS, B
KAREMAKER, JM
WEMER, J
VANBOXTEL, CJ
机构
[1] UNIV AMSTERDAM,ACAD MED CTR,DEPT PHARMACOL,1105 AZ AMSTERDAM,NETHERLANDS
[2] UNIV AMSTERDAM,ACAD MED CTR,DEPT PHYSIOL,1105 AZ AMSTERDAM,NETHERLANDS
关键词
D O I
10.1007/BF00542442
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:395 / 400
页数:6
相关论文
共 30 条
[1]   ABSORPTION AND EXCRETION OF RAPID AND SLOW RELEASE OXPRENOLOL AND THEIR EFFECTS ON HEART-RATE AND BLOOD-PRESSURE DURING EXERCISE [J].
BOBIK, A ;
JENNINGS, GL ;
KORNER, PI ;
ASHLEY, P ;
JACKMAN, G .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (06) :545-549
[2]   RELATION BETWEEN PLASMA CONCENTRATIONS AND CARDIOVASCULAR EFFECTS OF ORAL OXPRENOLOL IN MAN [J].
BRUNNER, L ;
IMHOF, P ;
JACK, D .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 8 (01) :3-9
[3]  
CRAIG MWM, 1981, J CARDIOVASC PHARM, V3, P468
[4]   PHARMACOLOGICAL STUDIES WITH SLOW-RELEASE FORMULATIONS OF OXPRENOLOL IN MAN [J].
DAVIDSON, C ;
THADANI, U ;
TAYLOR, SH ;
HESS, H ;
RIESS, W .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 10 (3-4) :189-195
[5]   CONSTANT KINETICS AND CONSTANT CONCENTRATION-EFFECT RELATIONSHIP DURING LONG-TERM BETA-BLOCKADE WITH PINDOLOL [J].
GALEAZZI, RL ;
PIROVINO, M ;
WEIDMANN, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (06) :733-740
[6]  
GIBALDI M, 1975, PHARMACOKINETICS
[7]  
GUGLER R, 1980, BRIT J CLIN PHARMACO, V10, P337
[8]   UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP - CLINICAL-APPLICATION OF PHARMACOKINETIC-PHARMACODYNAMIC MODELS [J].
HOLFORD, NHG ;
SHEINER, LB .
CLINICAL PHARMACOKINETICS, 1981, 6 (06) :429-453
[9]   CONCENTRATION-EFFECT AND TIME-EFFECT RELATIONSHIPS OF CARTEOLOL [J].
ISHIZAKI, T ;
OHNISHI, A ;
SASAKI, T ;
CHIBA, K ;
SUGANUMA, T ;
KUSHIDA, K .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (06) :749-757
[10]  
ISHIZAKI T, 1980, J PHARMACOL EXP THER, V212, P173